First Antibody Trial Launched in COVID-19 Patients
First Antibody Trial Launched in COVID-19 Patients
In record time, scientists have gone from harvesting antibodies against SARS-CoV-2 from survivors of coronavirus infections to testing the antibodies’ safety as a drug in humans.
In record time, scientists have gone from harvesting antibodies against SARS-CoV-2 from survivors of coronavirus infections to testing the antibodies’ safety as a drug in humans.
receptor binding sites
Using Sero-Surveillance to Combat the COVID-19 Pandemic
The Scientist and Bio-Rad Laboratories | Feb 7, 2022 | 1 min read
Immunoassays for detecting, tracking, and testing SARS-CoV-2 antibody responses
Deep Pocket Exploration
Ruth Williams | Feb 1, 2017 | 3 min read
A modification to traditional docking software enables the examination of a ligand’s passage into its receptor.
Yun “Nancy” Huang: Eager for Epigenetics
Amanda B. Keener | Aug 1, 2015 | 3 min read
Assistant Professor, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston. Age: 35